ResearcherUniversity of LiverpoolActive in the last 2 years
Teifion Luckett
Matched on ORCID iD 0009-0003-4675-2830; OpenAlex author ID A5073289616. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers
Papers 3
- Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. Co-author DOI 10.1158/0008-5472.can-23-1542↗
- Robust and consistent biomarker candidates identification by a machine learning approach applied to pancreatic ductal adenocarcinoma metastasis. First author DOI 10.1186/s12911-024-02578-0↗
- Blockade of Stromal Gas6 Alters Cancer Cell Plasticity, Activates NK Cells, and Inhibits Pancreatic Cancer Metastasis. First author DOI 10.3389/fimmu.2020.00297↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ainhoa Mielgo Iza · 3 shared papers, 2020–2024 · strength 0.64
- Paper Robust and consistent biomarker candidates identification by a machine learning approach applied to pancreatic ductal a… DOI 10.1186/s12911-024-02578-0↗
- Paper Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. DOI 10.1158/0008-5472.can-23-1542↗
- Paper Blockade of Stromal Gas6 Alters Cancer Cell Plasticity, Activates NK Cells, and Inhibits Pancreatic Cancer Metastasis. DOI 10.3389/fimmu.2020.00297↗
- Michael C. Schmid · 2 shared papers, 2020–2024 · strength 0.36
- Lucy Ireland · 2 shared papers, 2020–2024 · strength 0.36
- Tanakamol Mahawan · 1 shared paper, 2024 · strength 0.28
- Eva Caamaño‐Gutiérrez · 1 shared paper, 2024 · strength 0.28
- Robert Peter Jones · 1 shared paper, 2024 · strength 0.20
- Paula Ghaneh · 1 shared paper, 2024 · strength 0.20
- Gaia Bellomo · 1 shared paper, 2024 · strength 0.20
- Mark A. Glenn · 1 shared paper, 2024 · strength 0.20
- Christopher Michael Halloran · 1 shared paper, 2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.